Neuropathies - Guillain-Barré syndrome: rehabilitation
DOI:
https://doi.org/10.5935/0104-7795.20130015Keywords:
Guillain-Barre Syndrome, Rehabilitation, Practice Guidelines as TopicAbstract
Articles in the MedLine (PubMed) database and other research sources were reviewed, with no age limit. The search strategy used was based on structured questions in the P.I.C.O. format (from the initials: Patient, Intervention, Control and Outcome).
Downloads
References
Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653-66. DOI: http://dx.doi.org/10.1016/S0140-6736(05)67665-9
Atkinson SB, Carr RL, Maybee P, Haynes D. The challenges of managing and treating Guillain-Barré syndrome during the acute phase. Dimens Crit Care Nurs. 2006;25(6):256-63. DOI: http://dx.doi.org/10.1097/00003465-200611000-00003
Tse AC, Cheung RT, Ho SL, Chan KH. Guillain-Barré syndrome associated with acute hepatitis E infection. J Clin Neurosci. 2012;19(4):607-8. DOI: http://dx.doi.org/10.1016/j.jocn.2011.06.024
Haldeman D, Zulkosky K. Treatment and nursing care for a patient with Guillain-Barré syndrome. Dimens Crit Care Nurs. 2005;24(6):267-72. DOI: http://dx.doi.org/10.1097/00003465-200511000-00004
Khan F. Rehabilitation in Guillian Barre Syndrome. Aust Fam Physician. 2004;12(33):1013-7.
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Lancet. 1997;349(9047):225-30.
Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K. Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barré syndrome. Neurology. 1996;46(1):100-3. DOI: http://dx.doi.org/10.1212/WNL.46.1.100
van der Meché FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. N Engl J Med. 1992;326(17):1123-9.
Raphael JC, Chevret S, Harboun M, Jars-Guincestre MC; French Guillain-Barré Syndrome Cooperative Group. Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 days.J Neurol Neurosurg Psychiatry. 2001;71(2):235-8.
Khan F, Pallant JF, Amatya B, Ng L, Gorelik A, Brand C. Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barré syndrome: a randomized controlled trial. J Rehabil Med. 2011;43(7):638-46. DOI: http://dx.doi.org/10.2340/16501977-0826
Uchôa-Figueiredo LR, Negrini SB. Terapia ocupacional: diferentes práticas em hospital geral. Ribeirao Preto: Legis Summa; 2009.
Atkinson SB, Carr RL, Maybee P, Haynes D. The challenges of managing and treating Guillain-Barré syndrome during the acute phase. Dimens Crit Care Nurs. 2006;25(6):256-63. DOI: http://dx.doi.org/10.1097/00003465-200611000-00003
Jamshidi N, Rostami M, Najarian S, Menhaj MB, Saadatnia M, Firooz S. Modelling of human walking to optimise the function of ankle-foot orthosis in Guillan-Barré patients with drop foot. Singapore Med J. 2009;50(4):412-7.
Cazeiro APM, Bastos SM, Santos EA, Almeida MVM, Chagas JNM. A terapia ocupacional e as atividades de vida diária, atividades instrumentais da vida diária e tecnologia assistiva. Fortaleza: ABRATO; 2011.
Ripathi M, Kaushik S. Carbamezapine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Crit Care Med. 2000;28(3):655-8.
Pandey CK, Bose N, Garg G, Singh N, Baronia A, Agarwal A, Et al. Gabapentin for the treatment of pain in guillain-barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg. 2002;95(6):1719-23. DOI: http://dx.doi.org/10.1097/00000539-200212000-00046
Pandey CK, Raza M, Tripathi M, Navkar DV, Kumar A, Singh UK. The comparative evaluation of gabapentin and carbamazepine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Anesth Analg. 2005;101(1):220-5. DOI: http://dx.doi.org/10.1213/01.ANE.0000152186.89020.36
Haldeman D, Zulkosky K. Treatment and nursing care for a patient with Guillain-Barré syndrome. Dimens Crit Care Nurs. 2005;24(6):267-72. DOI: http://dx.doi.org/10.1097/00003465-200511000-00004
Sulton LL. Meeting the challenge of Guillain-Barré syndrome. Nurs Manage. 2002;33(7):25-30. DOI: http://dx.doi.org/10.1097/00006247-200207000-00016
Fourrier F, Robriquet L, Hurtevent JF, Spagnolo S. A simple functional marker to predict the need for prolonged mechanical ventilation in patients with Guillain-Barré syndrome. Crit Care. 2011;15(1):R65.
Nguyen TN, Badjatia N, Malhotra A, Gibbons FK, Qureshi MM, Greenberg SA. Factors predicting extubation success in patients with Guillain-Barré syndrome. Neurocrit Care. 2006;5(3):230-4. DOI: http://dx.doi.org/10.1385/NCC:5:3:230
Downloads
Published
Issue
Section
License
Copyright (c) 2013 Acta Fisiátrica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
